CRBU - Latest News

Caribou Biosciences, Inc. (CRBU), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $210.3M. Beta to the broader market is 2.27.

The article list below shows the most recent CRBU headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent CRBU Headlines

Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - May 15, 2026

Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

globenewswire.com - May 13, 2026

BERKELEY, Calif. , May 13, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc.

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

globenewswire.com - May 12, 2026

BERKELEY, Calif. , May 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc.

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

zacks.com - May 7, 2026

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.

Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update

globenewswire.com - May 7, 2026

-- Achieved alignment with FDA on pivotal ANTLER-3 trial design for vispa-cel in 2L LBCL -- -- Longer follow up on vispa-cel phase 1 clinical data exp

How News Affects CRBU Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CRBU's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked CRBU news questions

What is the latest CRBU news headline?

The most recent CRBU headline (May 15, 2026) is "Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Transcript". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the CRBU news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What CRBU news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual CRBU options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.